We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$670M
1-Year Est. Return
34.04%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+34.04%
3 Year Est. Return
+107.53%
5 Year Est. Return
+130.35%
10 Year Est. Return
+379.12%
AUM
$422M
AUM Growth
+$39.5M
(+10%)
Cap. Flow
+$5.79M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
29.7%
Holding
240
New
12
Increased
81
Reduced
118
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$5.19M |
| 2 |
UnitedHealth
UNH
|
+$3.72M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97M |
| 4 |
Dick's Sporting Goods
DKS
|
+$2.42M |
| 5 |
Air Products & Chemicals
APD
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.51M |
| 2 |
iShares US Medical Devices ETF
IHI
|
+$1.04M |
| 3 |
Medtronic
MDT
|
+$945K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$672K |
| 5 |
Corning
GLW
|
+$633K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.31% |
| 2 | Industrials | 12.36% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 10.86% |
| 5 | Communication Services | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Stryker
SYK
$130B
| $659K | 0.16% |
2,202
-2
| -0.1% | -$561 |
|
102
Alphabet (Google) Class C
GOOG
$4.19T
| $658K | 0.16% |
4,669
-120
| -3% | -$16.3K |
|
103
Pultegroup
PHM
$24.8B
| $649K | 0.15% |
6,283
-810
| -11% | -$68.8K |
|
104
First Trust Value Line Dividend Fund
FVD
$8.41B
| $639K | 0.15% |
15,755
+46
| +0.3% | +$1.76K |
|
105
ProShares Bitcoin Strategy ETF
BITO
$1.42B
| $632K | 0.15% |
+30,832
| New | +$558K |
|
106
PTC
PTC
$16.3B
| $628K | 0.15% |
3,591
-449
| -11% | -$68.9K |
|
107
Marathon Petroleum
MPC
$99.8B
| $606K | 0.14% |
4,082
-533
| -12% | -$79.2K |
|
108
Regeneron Pharmaceuticals
REGN
$82.8B
| $595K | 0.14% |
678
-89
| -12% | -$73.3K |
|
109
Arch Capital
ACGL
$33.7B
| $591K | 0.14% |
7,960
-986
| -11% | -$80.6K |
|
110
Halliburton
HAL
$28.8B
| $583K | 0.14% |
16,141
+760
| +5% | +$29.2K |
|
111
GE Aerospace
GE
$382B
| $574K | 0.14% |
5,637
-713
| -11% | -$66.1K |
|
112
Amphenol
APH
$206B
| $571K | 0.14% |
11,522
-1,486
| -11% | -$65.6K |
|
113
Vanguard Total World Stock ETF
VT
$81.8B
| $568K | 0.13% |
5,524
+67
| +1% | +$6.45K |
|
114
Occidental Petroleum
OXY
$58.3B
| $568K | 0.13% |
9,514
-1,372
| -13% | -$83.7K |
|
115
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.72B
| $567K | 0.13% |
+4,184
| New | +$515K |
|
116
TransDigm Group
TDG
$69.4B
| $558K | 0.13% |
552
+79
| +17% | +$72.9K |
|
117
Starbucks
SBUX
$123B
| $556K | 0.13% |
5,786
+38
| +0.7% | +$3.7K |
|
118
iShares Core S&P Small-Cap ETF
IJR
$114B
| $554K | 0.13% |
5,119
-183
| -3% | -$17.6K |
|
119
Invesco Large Cap Growth ETF
PWB
$2.45B
| $548K | 0.13% |
7,048
| – | – |
|
120
Automatic Data Processing
ADP
$108B
| $541K | 0.13% |
2,322
-91
| -4% | -$21.2K |
|
121
First Solar
FSLR
$24.2B
| $539K | 0.13% |
3,129
-577
| -16% | -$88.2K |
|
122
Oracle
ORCL
$433B
| $529K | 0.13% |
5,019
-952
| -16% | -$104K |
|
123
ExxonMobil
XOM
$658B
| $528K | 0.13% |
5,278
-551
| -9% | -$57.9K |
|
124
Take-Two Interactive
TTWO
$46.1B
| $527K | 0.13% |
3,275
-438
| -12% | -$65.4K |
|
125
Howmet Aerospace
HWM
$115B
| $526K | 0.12% |
9,713
-1,250
| -11% | -$61.7K |
|
Similar funds
TAP
CCM
BCP
AVM
FAM
MCO
CCG
PAI
Strategy Asset Managers's Q4 2023 Portfolio in Review
As of Q4 2023, Strategy Asset Managers held 240 positions worth $422M, up 10% from $382M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Strategy Asset Managers's Q4 2023 filing shows 12 new, 81 increased, 118 reduced and 12 closed positions. Its largest new stake was Dick's Sporting Goods: 19,908 shares worth $2.93M. The largest sale was Pfizer, an estimated $5.51M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
- Strategy Asset Managers's largest Q4 2023 buy was Dick's Sporting Goods: 19,908 shares worth $2.93M.
- Strategy Asset Managers added most to Eli Lilly in Q4 2023, an estimated $5.19M increase.
- Strategy Asset Managers's biggest Q4 2023 reduction was Pfizer, cutting an estimated $5.51M.
- Strategy Asset Managers fully exited iShares US Medical Devices ETF in Q4 2023, selling an estimated $1.04M.
- Strategy Asset Managers's ten largest holdings make up 30% of its $422M portfolio in Q4 2023.
- Strategy Asset Managers opened 12 new positions and closed 12 in Q4 2023.
- Strategy Asset Managers's portfolio value rose 10% quarter-over-quarter to $422M.
Based on Strategy Asset Managers's 13F filing for Q4 2023, filed 12 Feb 2024.